IRIS
SIVORI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.181
Totale 11.181
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.181
Totale 11.181
Salva come PNG Salva come JPEG
Città #
Genova 8.950
Rapallo 1.172
Genoa 1.009
Bordighera 46
Vado Ligure 4
Totale 11.181
Salva come PNG Salva come JPEG
Nome #
NK/DC crosstalk in anti-viral response. 153
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 152
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 149
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 147
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 143
Markers and function of human NK cells in normal and pathological conditions 142
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 138
2B4 functions as a co-receptor in human NK cell activation 137
NK cells and their receptors during viral infections. 137
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 137
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 136
Stimulatory receptors in NK and T cells. 134
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 133
Bridging innate NK cell Functions with Adaptive Immunity. 133
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 132
Features of Memory-Like and PD-1+ Human NK Cell Subsets 127
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products 124
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 124
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 124
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 122
Function and specificity of human natural killer cell receptors. 122
Pathogen-induced private conversations between natural killer and dendritic cells 121
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 120
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 120
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 120
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 119
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 118
Human NK receptors: from the molecules to the therapy of high risk leukemias. 117
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 115
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. 114
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients 113
Natural killer lymphocytes: "null cells" no more. 113
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 112
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 112
Harnessing NK Cells for Cancer Treatment 112
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. 111
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 111
CD56 is a pathogen recognition receptor on human natural killer cells 111
Human NK cell response to pathogens 110
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 109
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: novel insights on KIR polymorphism, ligand recognition, expression and function 109
Identification of a new surface molecule involved in the mechanism of cell to cell adhesion between human NK and tumor target cells. 108
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 108
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. 107
Natural killer cell-triggering receptors in patients with acute leukaemia. 105
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 104
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 104
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 103
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 102
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 102
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 101
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 101
TLR/NCR/KIR: Which One to Use and When? 101
Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering. 100
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. 100
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 100
NK Receptors: Tools for a Polyvalent Cell Family 100
NK cells: innate immunity against hematological malignancies? 100
General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. 99
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 99
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 98
Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. 97
Human natural killer cell receptors and co-receptors. 97
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 97
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4(+) T Lymphocytes of Sézary Syndrome Patients. 96
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. 96
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 96
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 95
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 92
Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. 91
In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-like Receptor 4 and Induces Activation of Monocytes. 90
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. 88
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. 88
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications 88
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 87
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. 86
NK Cell-Based Immunotherapy for Hematological Malignancies 84
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 82
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 81
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 80
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 80
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 80
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 79
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 79
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. 77
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 77
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. 77
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 76
ANALYSIS OF THE INTERACTION OF MATURING NK CELLS WITHREPLICATING VIRUSES: STRONG UPREGULATION OF NCREXPRESSION AND OF CYTOTOXICITY BY HSV-1, NOT BY HIV-1 76
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 75
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 73
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 72
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 72
High performance liquid chromatographic strategy for the analysis of exopolysaccharides extracted from pathogenic bacteria. 70
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 70
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 66
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content 66
Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. 66
NK-DC intercourse during inflammation 65
Il recettore NK per gli alleli HLA-Bw4 62
Totale 10.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.964
article - articoli 28.540
book - libri 520
conference - conferenze 2.301
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 603
Totale 63.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.360 140 79 122 209 341 382 481 243 330 571 349 113
2020/20211.091 76 84 95 65 46 164 75 68 107 135 85 91
2021/20221.471 57 107 130 149 53 91 80 331 72 152 67 182
2022/20231.445 156 109 17 148 224 247 2 122 257 10 129 24
2023/2024773 48 94 17 93 71 76 36 78 56 46 47 111
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 11.447